日本专家共识:PCT指导抗菌治疗的算法
2016年日本通过国家抗微生物耐药(AMR)行动计划,倡导到2020年抗生素消耗量减少20%。多项随机对照试验报告,PCT指导的抗菌治疗有助于减少抗生素消耗且无不良健康影响,尤其在急性呼吸道感染中。2018年9月欧美专家提出ICU外轻中度感染和ICU内重症感染的PCT指导算法(国际专家共识)。此后,包括重症医学、急诊医学、呼吸医学和感染病学专家在内的日本专家组制定了改良版PCT指导算法(日本专家共识),以适应日本医疗环境,因PCT指导治疗在日本日常临床实践中尚未广泛使用。
要点
- 日本2016年通过国家AMR行动计划,倡导到2020年抗生素消耗量减少20%。
- 多项RCT报告PCT指导抗菌治疗有助于减少抗生素消耗且无不良健康影响,尤其在急性呼吸道感染中。
- 2018年9月欧美专家提出ICU外轻中度感染和ICU内重症感染的PCT指导算法(国际专家共识)。
- 日本改良算法目标患者限于住院ICU或非ICU患者,排除铜绿假单胞菌、金黄色葡萄球菌和军团菌所致肺炎。
- 日本算法提出不同的PCT随访测量时机,以适应日本医疗保险制度的限制。
适用人群与场景
- 目标患者限于住院ICU或非ICU患者。
- 排除铜绿假单胞菌、金黄色葡萄球菌和军团菌所致肺炎。
处置流程与药物剂量
- 日本改良算法提出不同的PCT随访测量时机,以适应日本医疗保险制度的限制。
研究设计与关键结果
- 日本专家组(包括重症医学、急诊医学、呼吸医学和感染病学专家)制定了改良版PCT指导算法(日本专家共识),以适应日本医疗环境。
- 日本算法有三个特点:目标患者限于住院ICU或非ICU患者;排除铜绿假单胞菌、金黄色葡萄球菌和军团菌所致肺炎;提出不同的PCT随访测量时机以适应日本医疗保险制度限制。
- 改良算法有高度潜力进一步改善日本安全减少抗生素消耗,同时减少AMR病原体传播。
证据类型、等级与局限
- 证据类型:专家共识。
- 多项随机对照试验报告PCT指导抗菌治疗有助于减少抗生素消耗且无不良健康影响,尤其在急性呼吸道感染中。
- 局限:原文未报告局限性。
对床旁实践的改变
- 日本专家共识的改良PCT指导算法目标患者限于住院ICU或非ICU患者。
- 该算法排除铜绿假单胞菌、金黄色葡萄球菌和军团菌所致肺炎。
- 该算法提出不同的PCT随访测量时机,以适应日本医疗保险制度的限制。
指南或共识出处
- 日本专家共识(Japanese experts consensus)。
- 国际专家共识(international experts consensus),2018年9月由欧美专家提出。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
In Japan, a national antimicrobial resistance (AMR) action plan was adopted in 2016, advocating a 20% reduction in antibiotic consumption by 2020. However, there is still room for improvement to accomplish this goal. Many randomized controlled trials have reported that procalcitonin (PCT)-guided antimicrobial therapy could help to reduce antibiotic consumption without negative health effects, specifically in acute respiratory infections. In September 2018, some experts in Europe and the USA proposed algorithms for PCT-guided antimicrobial therapy in mild to moderate infection cases outside the ICU and severe cases in the ICU (the international experts consensus). Thereafter, a group of Japanese experts, including specialists in intensive care medicine, emergency medicine, respiratory medicine and infectious diseases, created a modified version of a PCT-guided algorithm (Japanese experts consensus). This modified algorithm was adapted to better fit Japanese medical circumstances, since PCT-guided therapy is not widely used in daily clinical practice in Japan. The Japanese algorithm has three specific characteristics. First, the target patients are limited to only hospitalized ICU or non-ICU patients. Second, pneumonia due to Pseudomonas aeruginosa, Staphylococcus aureus and Legionella species are excluded. Finally, a different timing of PCT follow-up measurement was proposed to meet restrictions of the Japanese medical insurance system. The adapted algorithms has high potential to further improve the safe reduction in antibiotic consumption in Japan, while reducing the spread of AMR pathogens.
参考来源
- Ito A, Shime N, Fujishima S, et al. An algorithm for PCT-guided antimicrobial therapy: a consensus statement by Japanese experts. Clin Chem Lab Med. 2022. PMID: 36453810. doi:10.1515/cclm-2022-1048
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。